All the events here are relevant to people working in dementia research. If you would like to add your own you can submit an event
- This event has passed.
Translating Novel Diagnostics into Practice
November 4 @ 3:00 pm - 5:00 pm
VJNeurology are excited to announce that we will be hosting a live webinar on Translating Novel Diagnostics into Practice: Updates for Neurodegenerative Diseases, as part of our series of live webinars focusing on key advances from 2024 in the diagnosis, treatment, and management of neurological disorders.
4 Nov 2024 | 9:00-11:00 CST / 15:00-17:00 GMT / 16:00-18:00 CET
Chaired by Professor Charlotte Teunissen, Amsterdam UMC, Netherlands
Co-moderated by Dr Nicholas Ashton, University of Gothenburg, Sweden & Professor Malú G. Tansey, University of Florida, USA
Please note this webinar is open to healthcare professionals, allied health professionals & researchers only. Your application will be reviewed and confirmed once received.
Agenda
Session 1: Updates in Parkinson’s disease
Abstract TBC
Speaker: TBC
Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset
Hällqvist J, et al. Nat Commun. 2024;15(1):4759
Speaker: Michael Bartl
Abstract TBC
Speaker: TBC
Panel discussion
Session 2: Role of tau biomarkers in Alzheimer’s disease diagnosis and staging
Abstract TBC
Speaker: TBC
Abstract TBC
Speaker: TBC
Panel discussion
Session 3: Utility of blood and fluid biomarkers for Alzheimer’s disease
Plasma protein profiling reveals novel and specific biomarkers reflecting the multifactorial nature of clinical stages in Alzheimer’s disease
ADPD 2024
Speaker: Giovanni Bellomo
Blood biomarkers to detect Alzheimer disease in primary care and secondary care
Palmqvist S, et al. JAMA. July 28 2024:e2413855
Speaker: Sebastian Palmqvist
Abstract TBC
Speaker: TBC
Novel body fluid biomarkers specific for different dementias. A strategy towards clinical use
ADPD 2024
Speaker: Charlotte Teunissen
Panel discussion
Session 4: Guidelines and recommendations for dementia diagnosis and staging
Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup
Jack CR Jr, et al. Alzheimers Dement. 2024;20(8):5143–69
Speaker: Clifford R. Jack Jr
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
Frisoni GB, et al. Lancet Neurol. 2024;23(3):302–12
Speaker: Federico Massa
Acceptable performance of blood biomarker tests of amyloid pathology – recommendations from the global CEO initiative on Alzheimer’s disease
Schindler SE, et al. Nat Rev Neurol. 2024;20(7):426–39
Speaker: Suzanne Schindler
Panel discussion
Session 5: Additional advances in dementia detection
Validation of Icobrain Aria – An AI-based software tool for automated detection and quantification of amyloid-related imaging abnormalities
AAN 2024
Speaker: Dirk Smeets
A novel immunoassay to measure CSF DOPA-decarboxylase, a promising biomarker candidate for dementia with Lewy bodies
ADPD 2024
Speaker: Katharina Bolsewig
Panel discussion
